Financials
- Market Capitalization 6.27 M
- Employee 6
- Founded 2016
- CEO N/A
- Website www.alzamend.com
- Headquarter Delaware, United States
- FIGI BBG00ZMXG7M8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.43
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4770 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.23 USD | -3.91% | -5.38% | -12.14% | -35.94% | 6.48 M USD | ||
| 4776 | ENVB Enveric Biosciences, Inc. - Common Stock | 1.43 USD | -2.72% | -3.38% | -3.38% | -41.75% | 6.40 M USD | ||
| 4779 | TRAW Traws Pharma, Inc. - Common Stock | 0.41 USD | -2.38% | -21.15% | -29.31% | -85.81% | 6.30 M USD | ||
| 4786 | IMNN Imunon, Inc. - Common Stock | 1.03 USD | -3.74% | -14.17% | -29.93% | -68.31% | 5.78 M USD |